An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema

Click on image to view larger version.

TABLE 1.

This Article

  1. Published in Advance November 21, 2018, doi: 10.1261/rna.068916.118 RNA 25: 255-263

Current Issue

  1. August 2026, 32 (8)
  1. Current Issue
  1. Alert me to new issues of RNA